Literature DB >> 17914180

Magnetic resonance microscopy and immunohistochemistry of the CNS of the mutant SOD murine model of ALS reveals widespread neural deficits.

M S Petrik1, J M B Wilson, S C Grant, S J Blackband, R C Tabata, X Shan, C Krieger, C A Shaw.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that primarily affects motor neurons and descending motor tracts of the CNS. We have evaluated the CNS of a murine model of familial ALS based on the over-expression of mutant human superoxide dismutase (mSOD; G93A) using magnetic resonance microscopy (MRM) and immunohistochemistry (IHC). Three-dimensional volumetric analysis was performed from 3D T2*-weighted images acquired at 17.6 T at isotropic resolutions of 40 mum. Compared to controls, mSOD mice had significant reductions in the volumes of total brain, substantia nigra, striatum, hippocampus, and internal capsule, with decreased cortical thickness in primary motor and somatosensory cortices. In the spinal cord, mSOD mice had significantly decreased volume of both the total grey and white matter; in the latter case, the volume change was confined to the dorsal white matter. Increased apoptosis, GFAP positive astrocytes, and/or activated microglia were observed in all those CNS regions that showed volume loss except for the hippocampus. The MRM findings in mSOD over-expressing mice are similar to data previously obtained from a model of ALS-parkinsonism dementia complex (ALS-PDC), in which neural damage occurred following a diet of washed cycad flour containing various neurotoxins. The primary difference between the two models involves a significantly greater decrease in spinal cord white matter volume in mSOD mice, perhaps reflecting variations in degeneration of the descending motor tracts. The extent to which several CNS structures are impacted in both murine models of ALS argues for a reevaluation of the nature of the pathogenesis of ALS since CNS structures involved in Parkinson's and Alzheimer's diseases appear to be affected as well.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17914180     DOI: 10.1007/s12017-007-8002-1

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  52 in total

1.  MRI of the intracranial corticospinal tracts in amyotrophic and primary lateral sclerosis.

Authors:  P Peretti-Viton; J P Azulay; S Trefouret; H Brunel; C Daniel; J M Viton; A Flori; B Salazard; J Pouget; G Serratrice; G Salamon
Journal:  Neuroradiology       Date:  1999-10       Impact factor: 2.804

Review 2.  Amyotrophic lateral sclerosis: current understanding.

Authors:  T Charles; M Swash
Journal:  J Neurosci Nurs       Date:  2001-10       Impact factor: 1.230

3.  ALS--not what we thought.

Authors:  Michael J Strong
Journal:  Arch Neurol       Date:  2006-03

Review 4.  Early diagnosis of ALS/MND.

Authors:  M Swash
Journal:  J Neurol Sci       Date:  1998-10       Impact factor: 3.181

5.  Lumbar motoneuron fate in a mouse model of amyotrophic lateral sclerosis.

Authors:  Dwayne K Hamson; Jie Hong Hu; Charles Krieger; Neil V Watson
Journal:  Neuroreport       Date:  2002-12-03       Impact factor: 1.837

6.  Familial ALS: clinical, genetic and morphological features.

Authors:  M Armani; S Pierobon-Bormioli; M L Mostacciuolo; M Cacciavillani; M A Cassol; R M Candeago; C Angelini
Journal:  Adv Exp Med Biol       Date:  1987       Impact factor: 2.622

7.  A three-dimensional digital atlas database of the adult C57BL/6J mouse brain by magnetic resonance microscopy.

Authors:  Y Ma; P R Hof; S C Grant; S J Blackband; R Bennett; L Slatest; M D McGuigan; H Benveniste
Journal:  Neuroscience       Date:  2005-09-13       Impact factor: 3.590

8.  Pursuit of the origin of the large myelinated fibers of the anterolateral funiculus in the spinal cord in humans in relation to the pathomechanism in amyotrophic lateral sclerosis.

Authors:  K Oyanagi; E Kawakami; T Morita; H Takahashi
Journal:  Acta Neuropathol       Date:  1999-12       Impact factor: 17.088

9.  Quantitative measurement of neurodegeneration in an ALS-PDC model using MR microscopy.

Authors:  J M B Wilson; M S Petrik; S C Grant; S J Blackband; J Lai; C A Shaw
Journal:  Neuroimage       Date:  2004-09       Impact factor: 6.556

10.  Magnetic resonance imaging reveals neuronal degeneration in the brainstem of the superoxide dismutase 1 transgenic mouse model of amyotrophic lateral sclerosis.

Authors:  Da Wei Zang; Qing Yang; Hong Xin Wang; Gary Egan; Elizabeth C Lopes; Surindar S Cheema
Journal:  Eur J Neurosci       Date:  2004-10       Impact factor: 3.386

View more
  11 in total

1.  The primary locus of motor neuron death in an ALS-PDC mouse model.

Authors:  Grace Lee; Tony Chu; Christopher A Shaw
Journal:  Neuroreport       Date:  2009-09-23       Impact factor: 1.837

2.  In vitro effects of cholesterol β-D-glucoside, cholesterol and cycad phytosterol glucosides on respiration and reactive oxygen species generation in brain mitochondria.

Authors:  Alexander Panov; Nataliya Kubalik; Benjamin R Brooks; Christopher A Shaw
Journal:  J Membr Biol       Date:  2010-10-12       Impact factor: 1.843

Review 3.  Neurodegenerative diseases: neurotoxins as sufficient etiologic agents?

Authors:  Christopher A Shaw; Günter U Höglinger
Journal:  Neuromolecular Med       Date:  2007-11-06       Impact factor: 3.843

4.  Imaging of brain TSPO expression in a mouse model of amyotrophic lateral sclerosis with (18)F-DPA-714 and micro-PET/CT.

Authors:  S Gargiulo; S Anzilotti; A R D Coda; M Gramanzini; A Greco; M Panico; A Vinciguerra; A Zannetti; C Vicidomini; F Dollé; G Pignataro; M Quarantelli; L Annunziato; A Brunetti; M Salvatore; S Pappatà
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-01-27       Impact factor: 9.236

Review 5.  White matter microglia heterogeneity in the CNS.

Authors:  Sandra Amor; Niamh B McNamara; Emma Gerrits; Manuel C Marzin; Susanne M Kooistra; Veronique E Miron; Erik Nutma
Journal:  Acta Neuropathol       Date:  2021-12-08       Impact factor: 17.088

Review 6.  Neuroimmunity dynamics and the development of therapeutic strategies for amyotrophic lateral sclerosis.

Authors:  Melissa Bowerman; Thierry Vincent; Frédérique Scamps; Florence E Perrin; William Camu; Cédric Raoul
Journal:  Front Cell Neurosci       Date:  2013-11-19       Impact factor: 5.505

Review 7.  The ubiquitin proteasome system in glia and its role in neurodegenerative diseases.

Authors:  Anne H P Jansen; Eric A J Reits; Elly M Hol
Journal:  Front Mol Neurosci       Date:  2014-08-08       Impact factor: 5.639

8.  Type I Vs. Type II Cytokine Levels as a Function of SOD1 G93A Mouse Amyotrophic Lateral Sclerosis Disease Progression.

Authors:  Amilia Jeyachandran; Benjamin Mertens; Eric A McKissick; Cassie S Mitchell
Journal:  Front Cell Neurosci       Date:  2015-12-01       Impact factor: 5.505

9.  Disruption of orbitofrontal-hypothalamic projections in a murine ALS model and in human patients.

Authors:  David Bayer; Stefano Antonucci; Hans-Peter Müller; Rami Saad; Luc Dupuis; Volker Rasche; Tobias M Böckers; Albert C Ludolph; Jan Kassubek; Francesco Roselli
Journal:  Transl Neurodegener       Date:  2021-05-31       Impact factor: 8.014

10.  In Vivo 3D Digital Atlas Database of the Adult C57BL/6J Mouse Brain by Magnetic Resonance Microscopy.

Authors:  Yu Ma; David Smith; Patrick R Hof; Bernd Foerster; Scott Hamilton; Stephen J Blackband; Mei Yu; Helene Benveniste
Journal:  Front Neuroanat       Date:  2008-04-17       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.